Literature DB >> 9192464

Cytochrome P450 3A4 mediated metabolism of 2,4-dichlorophenol.

Z Mehmood1, D E Kelly, S L Kelly.   

Abstract

The metabolism of the environmental pollutant and hepatocarcinogen 2,4-dichlorophenol (2,4-DCP) was studied using microsomal fractions and whole-cells of Saccharomyces cerevisiae containing human cytochrome P450 3A4. 2,4-DCP exhibited a typical type I substrate binding spectrum with a K, of 75 microM. 2,4-DCP was metabolised into two major metabolites identified as 2-chloro-1,4-hydroxyquinone and 2-chloro-1,4-benzoquinone in microsomal fractions and whole cells of yeast expressing human cytochrome P450 3A4. A further metabolite, 1,2,4-hydroxybenzene, was also detected during biotransformation by whole cells, but was not observed in microsomal fractions. 2,4-DCP metabolism was dependent on NADPH in microsomal fractions and no activity was observed in microsomal fractions or whole cells of control transformants. Metabolites were identified by TLC followed by GC-MS.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9192464     DOI: 10.1016/s0045-6535(97)00040-4

Source DB:  PubMed          Journal:  Chemosphere        ISSN: 0045-6535            Impact factor:   7.086


  3 in total

1.  Comparison of microbial hosts and expression systems for mammalian CYP1A1 catalysis.

Authors:  Sjef Cornelissen; Mattijs K Julsing; Andreas Schmid; Bruno Bühler
Journal:  J Ind Microbiol Biotechnol       Date:  2011-08-24       Impact factor: 3.346

2.  Structure-Based Inhibitor Design for Evaluation of a CYP3A4 Pharmacophore Model.

Authors:  Parminder Kaur; A Richard Chamberlin; Thomas L Poulos; Irina F Sevrioukova
Journal:  J Med Chem       Date:  2015-09-24       Impact factor: 7.446

3.  Photosensitive Ru(II) Complexes as Inhibitors of the Major Human Drug Metabolizing Enzyme CYP3A4.

Authors:  Nicholas Toupin; Sean J Steinke; Sandeep Nadella; Ao Li; Thomas N Rohrabaugh; Eric R Samuels; Claudia Turro; Irina F Sevrioukova; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2021-06-10       Impact factor: 16.383

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.